Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapproved, ...

Bagsværd, Denmark, 3 February 2026 – Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for 2025 and released the 2026 full-year sales and operating profit ...

Learn how to use and get the most from Google Docs, Sheets, Slides, Meet, Keep, Forms, Gmail, and other apps in Google’s Workspace productivity suite. From its humble origins as a collection of cloud ...

Minecraft remains one of the best games of all time over a decade on from its release, but spending such a long time in one game could lead to you running out of ideas. We've been there: you've ...

Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving patients and putting their health at risk Novo Nordisk takes decisive legal ...

Abstract: Generative artificial intelligence has become the focus of the intelligent education field, especially in the generation of personalized learning resources. Current learning resource ...

Abstract: Intelligent reflecting surface (IRS) is an enabling technology to engineer the radio signal propagation in wireless networks. By smartly tuning the signal reflection via a large number of ...

SimFin is a database with financial data such as Income Statements, Balance Sheets and Cash Flow Statements, along with a simple Python API for downloading and using the data. These tutorials show how ...

Note The "current" best practices that are detailed in this workflow were set up in 2019. Thus, they do not necessarily follow the latest best practices for scRNA-seq analysis anymore. For an ...

Bagsværd, Denmark, 4 February 2026 - Today, Novo Nordisk A/S has issued its 2025 annual report. The report is available here: https://www.novonordisk.com/investors ...

Bagsværd, Denmark, 4 February 2026 –The execution of Novo Nordisk A/S’ overall share repurchase programme for 2026 of up to DKK 15 billion will be initiated on 4 February 2026. As part of this, Novo ...